SIP
WST icon

Stoneridge Investment Partners’s West Pharmaceutical WST Stock Holding History

Stoneridge Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,804
Closed -$1.53M – 317
2017
Q1 		$1.53M Buy
+18,804
New +$1.57M 0.21% 143

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Stoneridge Investment Partners's WST Position: Q2 2017 in Review

Stoneridge Investment Partners sold out of West Pharmaceutical (WST) in Q2 2017, closing a stake of 18,804 shares — an estimated $1.53M sold.

Stoneridge Investment Partners first reported a position in WST in Q1 2017 and held it in 1 quarter. The position peaked at $1.53M in Q1 2017. 309 funds tracked by Wall St. Rank hold WST as of Q2 2017.

  • Stoneridge Investment Partners reported no remaining West Pharmaceutical position as of Q2 2017 after selling out during the quarter.
  • Stoneridge Investment Partners sold 18,804 West Pharmaceutical shares in Q2 2017, an estimated $1.53M.
  • Stoneridge Investment Partners first reported a position in West Pharmaceutical in Q1 2017 and held it in 1 quarter.
  • Stoneridge Investment Partners's West Pharmaceutical position peaked at $1.53M in Q1 2017.
  • 309 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2017.

Based on Stoneridge Investment Partners's 13F filing for Q2 2017, filed 1 Aug 2017.